# Dexmedtomodine Effect on Agitated Psychotic Patients Suffer COPD

> **NCT06567587** · — · COMPLETED · sponsor: **Tanta University** · enrollment: 70 (actual)

## Conditions studied

- Response of Agitated Patients to Dexmedetomidine

## Interventions

- **DRUG:** Dexmedetomidine
- **DEVICE:** BIPAP

## Key facts

- **NCT ID:** NCT06567587
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-10
- **Primary completion:** 2024-11-10
- **Final completion:** 2025-03-10
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2026-01-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06567587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06567587, "Dexmedtomodine Effect on Agitated Psychotic Patients Suffer COPD". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06567587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*